Raymond James Financial’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.38M Sell
549,966
-16,001
-3% -$200K ﹤0.01% 2401
2025
Q4
$6.47M Sell
565,967
-88,629
-14% -$1.04M ﹤0.01% 2301
2025
Q3
$8.31M Buy
654,596
+56,889
+10% +$825K ﹤0.01% 2071
2025
Q2
$9.49M Sell
597,707
-119,594
-17% -$1.79M ﹤0.01% 1916
2025
Q1
$10.7M Buy
717,301
+172,795
+32% +$3.06M ﹤0.01% 1762
2024
Q4
$10.3M Buy
+544,506
New +$11.5M ﹤0.01% 1820

Other funds holding XRAY

Raymond James Financial's XRAY Position: Q1 2026 in Review

Raymond James Financial reduced its Dentsply Sirona (XRAY) stake by 2.8% in Q1 2026, selling an estimated $200K and leaving 549,966 shares worth $6.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2401.

Raymond James Financial first reported a position in XRAY in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.7M in Q1 2025. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Raymond James Financial held 549,966 shares of Dentsply Sirona worth $6.38M as of Q1 2026.
  • Raymond James Financial sold 16,001 Dentsply Sirona shares in Q1 2026, an estimated $200K.
  • Dentsply Sirona made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2401 holding.
  • Raymond James Financial first reported a position in Dentsply Sirona in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Dentsply Sirona position peaked at $10.7M in Q1 2025.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.